Secondulfo, C.; Russo, D.; Vecchione, N.; Minelli, G.; Apicella, L.; Iacuzzo, C.; Crescenzo, C.; Minco, M.; Sannino, A.; Clemente, G.;
et al. Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients. Int. J. Mol. Sci. 2026, 27, 4832.
https://doi.org/10.3390/ijms27114832
AMA Style
Secondulfo C, Russo D, Vecchione N, Minelli G, Apicella L, Iacuzzo C, Crescenzo C, Minco M, Sannino A, Clemente G,
et al. Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients. International Journal of Molecular Sciences. 2026; 27(11):4832.
https://doi.org/10.3390/ijms27114832
Chicago/Turabian Style
Secondulfo, Carmine, Dora Russo, Nicoletta Vecchione, Gianmarco Minelli, Luca Apicella, Candida Iacuzzo, Chiara Crescenzo, Maristella Minco, Anna Sannino, Gennaro Clemente,
and et al. 2026. "Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients" International Journal of Molecular Sciences 27, no. 11: 4832.
https://doi.org/10.3390/ijms27114832
APA Style
Secondulfo, C., Russo, D., Vecchione, N., Minelli, G., Apicella, L., Iacuzzo, C., Crescenzo, C., Minco, M., Sannino, A., Clemente, G., Pisani, A., Cirillo, M., & Bilancio, G.
(2026). Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients. International Journal of Molecular Sciences, 27(11), 4832.
https://doi.org/10.3390/ijms27114832